| Financial Year |
March 31 2023 |
| Monetary Funds |
3,740,932,254.78 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
36,326,939.70 |
| Accounts Receivable |
1,481,705,722.41 |
| Advances to Suppliers |
550,799,197.77 |
| Other Receivables |
1,335,557,607.27 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,729,947,887.70 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,010,434.92 |
| Other Current Assets |
117,343,534.48 |
| Total Current Assets |
12,431,658,674.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
34,952,317.96 |
| Long-term Equity Investment |
516,815,299.62 |
| Investment Properties |
207,514,704.82 |
| Fixed Assetes |
3,823,586,305.88 |
| Under-construction Projects |
450,720,480.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
9,445,956,262.71 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,836,660,110.41 |
| R&D expenses |
-- |
| Goodwill |
2,488,590,696.95 |
| Long-Term Deferred and Prepaid Expenses |
52,798,249.05 |
| Deferred Income Tax Assets |
270,789,743.02 |
| Other Non-Current Assets |
1,106,503,275.90 |
| Sub-Total of Non-Current Assets |
21,944,438,464.86 |
| Total Assets |
34,376,097,139.04 |
| Short-Term Loans |
6,660,773,002.35 |
| Trading Financial liabilities |
-- |
| Notes Payable |
20,000,000.00 |
| Accounts Payable |
626,804,504.66 |
| Accounts Received In Advance |
101,893,983.57 |
| Employee Compensation Payable |
232,543,244.91 |
| Taxes Payable |
135,279,456.37 |
| Interest Payable |
-- |
| Dividend Payable |
5,683,190.17 |
| Other payables |
1,016,530,034.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,405,890,030.95 |
| Other Current Liabilities |
144,599,471.47 |
| Sub-Total of Current Liabilities |
11,093,234,119.11 |
| Long-term Loans |
6,856,982,977.62 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
5,184,601.63 |
| Deferred Income Tax Liabilities |
274,956,429.60 |
| Other Non-Current Liabilities |
47,096,862.43 |
| Sub-Total of Non-Current Liabilities |
10,522,389,059.74 |
| Total Liabilities |
21,615,623,178.85 |
| Paid-In Capital(Or Share Stock) |
4,279,427,797.00 |
| Capital Surplus |
5,049,583,760.22 |
| Surplus Reserve |
447,125,036.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-169,959,132.98 |
| Minority Stockholder's Interest |
3,243,465,137.99 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,517,008,822.20 |
| Owner's Equity（Stockholder's Equity） |
12,760,473,960.19 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
34,376,097,139.04 |
